The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bleeding Disorders Market Research Report 2024
Synopsis
The bleeding disorder is a condition in which there is a problem associated with the normal blood clotting process in the body, which gets affected. Hence, therapies to stop bleeding are on high demand.
The global Bleeding Disorders market was valued at US$ 10810 million in 2023 and is anticipated to reach US$ 16780 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Bleeding Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bleeding Disorders.
Report Scope
The Bleeding Disorders market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bleeding Disorders market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bleeding Disorders companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Bayer
Baxter International
Alnylam Pharmaceuticals
Pfizer
Xenetic Biosciences
Bristol-Myers Squibb Company
Sanofi
Janssen Global Services
Bioverativ
Amgen
Segment by Type
Plasma-derived Coagulation Factor Concentrates
Recombinant Coagulation Factor Concentrates
Desmopressin
Antifibrinolytics
Fibrin Sealants
Others
Segment by Application
Hemophilia A
Hemophilia B
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bleeding Disorders companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The bleeding disorder is a condition in which there is a problem associated with the normal blood clotting process in the body, which gets affected. Hence, therapies to stop bleeding are on high demand.
The global Bleeding Disorders market was valued at US$ 10810 million in 2023 and is anticipated to reach US$ 16780 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Bleeding Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bleeding Disorders.
Report Scope
The Bleeding Disorders market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bleeding Disorders market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bleeding Disorders companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novo Nordisk
Bayer
Baxter International
Alnylam Pharmaceuticals
Pfizer
Xenetic Biosciences
Bristol-Myers Squibb Company
Sanofi
Janssen Global Services
Bioverativ
Amgen
Segment by Type
Plasma-derived Coagulation Factor Concentrates
Recombinant Coagulation Factor Concentrates
Desmopressin
Antifibrinolytics
Fibrin Sealants
Others
Segment by Application
Hemophilia A
Hemophilia B
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bleeding Disorders companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bleeding Disorders Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Plasma-derived Coagulation Factor Concentrates
1.2.3 Recombinant Coagulation Factor Concentrates
1.2.4 Desmopressin
1.2.5 Antifibrinolytics
1.2.6 Fibrin Sealants
1.2.7 Others
1.3 Market by Application
1.3.1 Global Bleeding Disorders Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hemophilia A
1.3.3 Hemophilia B
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bleeding Disorders Market Perspective (2019-2030)
2.2 Bleeding Disorders Growth Trends by Region
2.2.1 Global Bleeding Disorders Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bleeding Disorders Historic Market Size by Region (2019-2024)
2.2.3 Bleeding Disorders Forecasted Market Size by Region (2025-2030)
2.3 Bleeding Disorders Market Dynamics
2.3.1 Bleeding Disorders Industry Trends
2.3.2 Bleeding Disorders Market Drivers
2.3.3 Bleeding Disorders Market Challenges
2.3.4 Bleeding Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bleeding Disorders Players by Revenue
3.1.1 Global Top Bleeding Disorders Players by Revenue (2019-2024)
3.1.2 Global Bleeding Disorders Revenue Market Share by Players (2019-2024)
3.2 Global Bleeding Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bleeding Disorders Revenue
3.4 Global Bleeding Disorders Market Concentration Ratio
3.4.1 Global Bleeding Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bleeding Disorders Revenue in 2023
3.5 Bleeding Disorders Key Players Head office and Area Served
3.6 Key Players Bleeding Disorders Product Solution and Service
3.7 Date of Enter into Bleeding Disorders Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bleeding Disorders Breakdown Data by Type
4.1 Global Bleeding Disorders Historic Market Size by Type (2019-2024)
4.2 Global Bleeding Disorders Forecasted Market Size by Type (2025-2030)
5 Bleeding Disorders Breakdown Data by Application
5.1 Global Bleeding Disorders Historic Market Size by Application (2019-2024)
5.2 Global Bleeding Disorders Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bleeding Disorders Market Size (2019-2030)
6.2 North America Bleeding Disorders Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bleeding Disorders Market Size by Country (2019-2024)
6.4 North America Bleeding Disorders Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bleeding Disorders Market Size (2019-2030)
7.2 Europe Bleeding Disorders Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bleeding Disorders Market Size by Country (2019-2024)
7.4 Europe Bleeding Disorders Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bleeding Disorders Market Size (2019-2030)
8.2 Asia-Pacific Bleeding Disorders Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bleeding Disorders Market Size by Region (2019-2024)
8.4 Asia-Pacific Bleeding Disorders Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bleeding Disorders Market Size (2019-2030)
9.2 Latin America Bleeding Disorders Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bleeding Disorders Market Size by Country (2019-2024)
9.4 Latin America Bleeding Disorders Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bleeding Disorders Market Size (2019-2030)
10.2 Middle East & Africa Bleeding Disorders Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bleeding Disorders Market Size by Country (2019-2024)
10.4 Middle East & Africa Bleeding Disorders Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Detail
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Bleeding Disorders Introduction
11.1.4 Novo Nordisk Revenue in Bleeding Disorders Business (2019-2024)
11.1.5 Novo Nordisk Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Bleeding Disorders Introduction
11.2.4 Bayer Revenue in Bleeding Disorders Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Baxter International
11.3.1 Baxter International Company Detail
11.3.2 Baxter International Business Overview
11.3.3 Baxter International Bleeding Disorders Introduction
11.3.4 Baxter International Revenue in Bleeding Disorders Business (2019-2024)
11.3.5 Baxter International Recent Development
11.4 Alnylam Pharmaceuticals
11.4.1 Alnylam Pharmaceuticals Company Detail
11.4.2 Alnylam Pharmaceuticals Business Overview
11.4.3 Alnylam Pharmaceuticals Bleeding Disorders Introduction
11.4.4 Alnylam Pharmaceuticals Revenue in Bleeding Disorders Business (2019-2024)
11.4.5 Alnylam Pharmaceuticals Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Bleeding Disorders Introduction
11.5.4 Pfizer Revenue in Bleeding Disorders Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Xenetic Biosciences
11.6.1 Xenetic Biosciences Company Detail
11.6.2 Xenetic Biosciences Business Overview
11.6.3 Xenetic Biosciences Bleeding Disorders Introduction
11.6.4 Xenetic Biosciences Revenue in Bleeding Disorders Business (2019-2024)
11.6.5 Xenetic Biosciences Recent Development
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Company Detail
11.7.2 Bristol-Myers Squibb Company Business Overview
11.7.3 Bristol-Myers Squibb Company Bleeding Disorders Introduction
11.7.4 Bristol-Myers Squibb Company Revenue in Bleeding Disorders Business (2019-2024)
11.7.5 Bristol-Myers Squibb Company Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Bleeding Disorders Introduction
11.8.4 Sanofi Revenue in Bleeding Disorders Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 Janssen Global Services
11.9.1 Janssen Global Services Company Detail
11.9.2 Janssen Global Services Business Overview
11.9.3 Janssen Global Services Bleeding Disorders Introduction
11.9.4 Janssen Global Services Revenue in Bleeding Disorders Business (2019-2024)
11.9.5 Janssen Global Services Recent Development
11.10 Bioverativ
11.10.1 Bioverativ Company Detail
11.10.2 Bioverativ Business Overview
11.10.3 Bioverativ Bleeding Disorders Introduction
11.10.4 Bioverativ Revenue in Bleeding Disorders Business (2019-2024)
11.10.5 Bioverativ Recent Development
11.11 Amgen
11.11.1 Amgen Company Detail
11.11.2 Amgen Business Overview
11.11.3 Amgen Bleeding Disorders Introduction
11.11.4 Amgen Revenue in Bleeding Disorders Business (2019-2024)
11.11.5 Amgen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
